Curr Hepatology Rep (2017) 16:250–257 DOI 10.1007/s11901-017-0362-x PORTAL HYPERTENSION (J ABRALDES AND E TSOCHATZIS, SECTION EDITORS) Cardiovascular Effects of a Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis 1,2 2 1 Troels M. Busk & Søren Møller & Flemming Bendtsen Published online: 19 July 2017 Springer Science+Business Media, LLC 2017 . . Abstract Keywords Cirrhosis Chronic liver disease Portal . . Purpose of Review Insertion of a transjugular intrahepatic hypertension Cirrhotic cardiomyopathy TIPS portosystemic shunt (TIPS) has proven effective in alleviating complications to portal hypertension such as refractory ascites and variceal bleeding in patients with cirrhosis. Moreover, it Introduction increases survival in selected patient groups. However, TIPS also causes marked circulatory changes and a central concern The insertion of a transjugular intrahepatic portosystemic has been whether this could negatively affect cardiac function. shunt (TIPS) was primarily used for the treatment of acute Therefore, this review aims to critically discuss our knowl- variceal bleeding and prevention of re-bleeding in high-risk edge on cardiovascular effects of a TIPS in cirrhosis. patients, but nowadays it also plays an increasing role in the Recent Findings These suggest that TIPS does not worsen management of refractory ascites . The treatment has prov- cardiac function.
Current Hepatology Reports – Springer Journals
Published: Jul 19, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera